These compounds may interact with:
Polyadenylate-binding protein 1
Potentially involved in: substance-related disorder; carcinoma; premature ovarian failure; acquired immunodeficiency syndrome; relapsing-remitting multiple sclerosis; spinocerebellar ataxia type 2; cataract 7; rift valley fever; dyscalculia; bladder neoplasm; carcinoma, transitional cell; mammary neoplasms; acute quadriplegic myopathy; astrocytoma; down syndrome; duchenne muscular dystrophy; juvenile dermatomyositis; lung cancer; ovarian cancer; spina bifida
Disease data sourced from Pharos.